High IFN-gamma and TNF production by peripheral NK cells of Colombian patients with different clinical presentation of Plasmodium falciparum

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Agudelo, Olga ^a   Bueno, Julio ^a   Villa, Andres ^a   Maestre, Amanda ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR; NCAM1 PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ADULT; ARTICLE; CELL COUNT; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHILL; CLINICAL ARTICLE; CLINICAL FEATURE; COLOMBIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; FEMALE; FEVER; FLUORESCENCE ACTIVATED CELL SORTING; HEADACHE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTRACELLULAR SPACE; MALAISE; MALARIA FALCIPARUM; MALE; NATURAL KILLER CELL; PARASITEMIA; PERIPHERAL BLOOD MONONUCLEAR CELL; SWEATING; VOMITING; ADOLESCENT; FLOW CYTOMETRY; HUMAN EXPERIMENT; IMMUNOLOGY; MIDDLE AGED; PARASITOLOGY; PLASMODIUM FALCIPARUM; SECRETION;

ADOLESCENT; ADULT; ANTIGENS, CD56; CELL PROLIFERATION; COLOMBIA; FEMALE; FLOW CYTOMETRY; HUMAN EXPERIMENTATION; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84856591154     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-38     Document Type: Article

References (45)

1. Interpreting malaria age-prevalence and incidence curves: a simulation study of the effects of different types of heterogeneity. Ross A, Smith T, Malar J 2010 9 132 10.1186/1475-2875-9-132 20478060
2. Cambios en las concentraciones de retinol, hemoglobina y ferritina en nĩos Colombianos con malaria. Uscátegui RM, Correa AM, Carmona-Fonseca J, Biomedica 2009 29 270 281 20128352
3. Nutritional status of children with malaria in northwest Colombia. Uscátegui RM, Correa AM, Biomedica 2007 27 559 570 18320123
4. Malaria. Subdireccián de vigilancia y control en salud pública-Instituto Nacional de Salud, Boletín Epidemiolágico semanal 2009 52 4 5 21216839
5. WHO, World Malaria Report Geneva: World Health Organization 2010 238
6. Comportamiento de la malaria en colombia según los casos notificados al sivigila en 2009. Instituto Nacional de Salud, Informe Epidemiolágico Malaria 2010 1 5
7. Cell biology and immunology of malaria. Hafalla JC, Silvie O, Matuschewski K, Immunol Rev 2011 240 297 316 10.1111/j.1600-065X.2010.00988.x 21349101
8. Natural-killer cells and dendritic cells: "l'union fait la force". Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E, Blood 2005 106 2252 2258 10.1182/blood-2005-03-1154 15933055 (Pubitemid 41510793)
9. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. Robbins SH, Bessou G, Cornillon A, Zucchini N, Rupp B, Ruzsics Z, Sacher T, Tomasello E, Vivier E, Koszinowski UH, Dalod M, PLoS Pathog 2007 3 123 10.1371/journal.ppat.0030123 17722980 (Pubitemid 47359092)
10. NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Krebs P, Barnes MJ, Lampe K, Whitley K, Bahjat KS, Beutler B, Janssen E, Hoebe K, Blood 2009 113 6593 6602 10.1182/blood-2009-01-201467 19406986
11. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. Andrews DM, Estcourt MJ, Andoniou CE, Wikstrom ME, Khong A, Voigt V, Fleming P, Tabarias H, Hill GR, Van Der Most RG, Scalzo AA, Smyth MJ, Degli-Esposti MA, J Exp Med 2010 207 1333 1343 10.1084/jem.20091193 20513749
12. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Moretta A, Marcenaro E, Sivori S, Della Chiesa M, Vitale M, Moretta L, Trends Immunol 2005 26 668 675 10.1016/j.it.2005.09.008 16198147 (Pubitemid 41628200)
13. Innate or adaptive immunity? The example of natural killer cells. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S, Science 2011 331 44 49 10.1126/science.1198687 21212348
14. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Carson WE, Fehniger TA, Caligiuri MA, Eur J Immunol 1997 27 354 360 10.1002/eji.1830270203 9045904 (Pubitemid 27085237)
15. Two populations of CD56 (Leu19)+/CD16+ cells in bone marrow transplant recipients. Gottschalk LR, Bray RA, Kaizer H, Gebel HM, Bone Marrow Transplant 1990 5 259 264 1692496 (Pubitemid 20204443)
16. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Jacobs R, Hintzen G, Kemper A, Beul K, Kempf S, Behrens G, Sykora KW, Schmidt RE, Eur J Immunol 2001 31 3121 3127 10.1002/1521- 4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4 11592089
17. Experimental models of cerebral malaria. Engwerda C, Belnoue E, Grüner AC, Rénia L, Curr Top Microbiol Immunol 2005 297 103 143 10.1007/3-540-29967-X-4 16265904 (Pubitemid 41383379)
18. Parasite genetic diversity does not influence TNF-mediated effects on the virulence of primary rodent malaria infections. Long GH, Chan BH, Allen JE, Read AF, Graham AL, Parasitology 2006 133 673 684 10.1017/S003118200600117X 16978451 (Pubitemid 44763963)
19. Memory-like IFN- response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum. McCall MB, Roestenberg M, Ploemen I, Teirlinck A, Hopman J, de Mast Q, Dolo A, Doumbo OK, Luty A, Van Der Ven AJ, Hermsen CC, Sauerwein RW, Eur J Immunol 2010 40 3472 3477 10.1002/eji.201040587 21072880
20. WHO, Guidelines for the treatment of malaria Geneve: World Health Organization Second 2009 http://whqlibdoc.who.int/publications/2010/ 9789241547925-eng.pdf accessed 27 October 2011
21. Diagnástico microscápico de los parásitos de la malaria en la sangre. Lápez-Antũano F, Diagnástico de malariaVolumen 512 Washington: OPS-OMS, Lopez-Antũano F, Schmunis G, 1988 39 50 22334527
22. Early interactions between blood-stage Plasmodiu parasites and the immune system. Urban BC, Ing R, Stevenson MM, Curr Top Microbiol Immunol 2005 297 25 70 10.1007/3-540-29967-X-2 16265902 (Pubitemid 41383377)
23. NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells. Combe CL, Curiel TJ, Moretto MM, Khan IA, Infect Immun 2005 73 4913 4921 10.1128/IAI.73.8.4913-4921.2005 16041005 (Pubitemid 41105648)
24. The innate immune response against Leishmania parasites. Liese J, Schleicher U, Bogdan C, Immunobiology 2008 213 377 387 10.1016/j.imbio.2007.12. 005 18406382
25. Activation of human NK cells by malaria-infected red blood cells. Horowitz A, Riley EM, Methods Mol Biol 2010 612 429 446 10.1007/978-1-60761-362- 6-29 20033658
26. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. Moretta L, Moretta A, EMBO J 2004 23 255 259 10.1038/sj.emboj. 7600019 14685277 (Pubitemid 38294490)
27. The double life of NK receptors: stimulation or co-stimulation? Snyder MR, Weyand CM, Goronzy JJ, Trends Immunol 2004 25 25 32 10.1016/j.it.2003.10.011 14698281 (Pubitemid 38035203)
28. Lymphocyte-mediated cytotoxicity. Russell JH, Ley TJ, Annu Rev Immunol 2002 20 323 370 10.1146/annurev.immunol.20.100201.131730 11861606 (Pubitemid 34293428)
29. Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparu-infected erythrocytes. Artavanis-Tsakonas K, Riley EM, J Immunol 2002 169 2956 2963 12218109 (Pubitemid 35013137)
30. Activation of a subset of human NK cells upon contact with Plasmodium falciparuminfected erythrocytes. Artavanis-Tsakonas K, Eleme K, McQueen KL, Cheng NW, Parham P, Davis DM, Riley EM, J Immunol 2003 171 5396 5405 14607943 (Pubitemid 37432826)
31. Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparu infections. Hermsen CC, Konijnenberg Y, Mulder L, Loé C, van Deuren M, Van Der Meer JW, van Mierlo GJ, Eling WM, Hack CE, Sauerwein RW, Clin Exp Immunol 2003 132 467 472 10.1046/j.1365-2249.2003.02160.x 12780694 (Pubitemid 36713953)
32. Dynamics and kinetics of natural killer cell cytotoxicity in human malaria as evaluated by a novel stepwise cytotoxicity assay. Ribeiro-Dias F, Tosta CE, Rev Soc Bras Med Trop 2006 39 357 364 17119751 (Pubitemid 44476863)
33. Characterization of peripheral blood lymphocyte subsets in patients with acute Plasmodium falciparu and P. viva malaria infections at Wonji Sugar Estate, Ethiopia. Kassa D, Petros B, Mesele T, Hailu E, Wolday D, Clin Vaccine Immunol 2006 13 376 379 10.1128/CVI.13.3.376-379.2006 16522780
34. Determination of the expression of lymphocyte surface markers and cytokine levels in a mouse model of Plasmodium berghe. Dogruman-Al F, Fidan I, Kustimur S, Ceber K, Imir T, New Microbiol 2009 32 285 291 19845111
35. A community study of T lymphocyte subsets and malaria parasitaemia. Lisse IM, Aaby P, Whittle H, Knudsen K, Trans R Soc Trop Med Hyg 1994 88 709 710 10.1016/0035-9203(94)90242-9 7886782
36. Immunological alterations associated with Plasmodium viva malaria in South Korea. Lee HK, Lim J, Kim M, Lee S, Oh EJ, Lee J, Oh J, Kim Y, Han K, Lee EJ, et al. Ann Trop Med Parasitol 2001 95 31 39 10.1080/00034980020035898 11235551 (Pubitemid 32178730)
37. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparu malaria. Hviid L, Kurtzhals JA, Goka BQ, Oliver-Commey JO, Nkrumah FK, Theander TG, Infect Immun 1997 65 4090 4093 9317012 (Pubitemid 27422063)
38. Heterogeneous human NK cell responses to Plasmodium falciparu-infected erythrocytes. Korbel DS, Newman KC, Almeida CR, Davis DM, Riley EM, J Immunol 2005 175 7466 7473 16301654 (Pubitemid 41713444)
39. Effect of nutrient deficiencies on in vitro Th1 and Th2 cytokine response of peripheral blood mononuclear cells to Plasmodium falciparu infection. Mbugi EV, Meijerink M, Veenemans J, Jeurink PV, McCall M, Olomi RM, Shao JF, Chilongola JO, Verhoef H, Savelkoul HF, Malar J 2010 9 162 10.1186/1475-2875-9- 162 20546583
40. Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-gamma responses to malaria. Newman KC, Korbel DS, Hafalla JC, Riley EM, PLoS Pathog 2006 2 118 10.1371/journal.ppat.0020118 17154717 (Pubitemid 46045199)
41. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals. Korbel DS, Norman PJ, Newman KC, Horowitz A, Gendzekhadze K, Parham P, Riley EM, J Immunol 2009 182 6426 6434 10.4049/jimmunol.0804224 19414796
42. Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparu-infected erythrocytes. Horowitz A, Newman KC, Evans JH, Korbel DS, Davis DM, Riley EM, J Immunol 2010 184 6043 6052 10.4049/jimmunol.1000106 20427769
43. Host-parasite interaction and morbidity in malaria endemic areas. Marsh K, Snow RW, Philos Trans R Soc Lond B Biol Sci 1997 352 1385 1394 10.1098/rstb.1997.0124 9355131 (Pubitemid 27434104)
44. Pathogenic T cells in cerebral malaria. Rénia L, Potter SM, Mauduit M, Rosa DS, Kayibanda M, Deschemin JC, Snounou G, Grüner AC, Int J Parasitol 2006 36 547 554 10.1016/j.ijpara.2006.02.007 16600241
45. The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Artavanis-Tsakonas K, Tongren JE, Riley EM, Clin Exp Immunol 2003 133 145 152 10.1046/j.1365-2249.2003.02174.x 12869017 (Pubitemid 36918587)